Axsome Therapeutics AXSM Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Axsome Therapeutics's current debt?
- Axsome Therapeutics (AXSM) reported current debt of $70M in Q1 2026.
- What does current debt mean?
- The amount of long-term debt that must be paid back within one year.
- How do you interpret current debt?
- Higher values indicate increased near-term liquidity pressure, while lower values suggest a more manageable debt maturity profile.
- How does current debt compare across companies?
- Highly comparable across all capital-intensive industries.